SCHEMBL31494283

SCHEMBL31494283

Nc1c(C(=O)O)cccc1S(=O)(=O)N1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 12/20 0.52
TGM1 P22735 11/20 0.52
F13A1 P00488 10/20 0.52
TGM3 Q08188 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.47
CYP2C19 P33261 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TSHR P16473 2/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 2/20 0.45
TP53 P04637 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27046568 1.00 TGM2 (0.52) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL27046571 0.85 TGM2 (0.50) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL10064223 0.79 TGM2 (0.70) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL1872113 0.78 TGM2 (0.67) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL1878082 0.77 TGM2 (0.69) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL6237772 0.76 MEN1 (0.61) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL12061638 0.76 TGM2 (0.63) TGM2TGM1F13A1TGM3SMN1; SMN2
SCHEMBL4814264 0.75 MEN1 (0.76) SMN1; SMN2CYP2C19KMT2AMEN1NPSR1
SCHEMBL3970912 0.75 MEN1 (0.76) SMN1; SMN2CYP2C19KMT2AMEN1NPSR1
SCHEMBL7393652 0.75 MEN1 (0.76) SMN1; SMN2CYP2C19KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251620-B1 AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS CHIESI FARM SPA (IT) 2025-04-16 EP disclosed